Clinical and prognostic importance of assessment of interleukin-12 blood concentration in patients with multifocal atherosclerosis after carotid endarterectomy
Abstract
54 patients, who were in the surgical department for subsequent carotid endarterectomy, were analyzed. Depending on long-term one-year prognosis all patients have been divided into two groups: with unfavorable (34 individuals – 62.9 %) and favorable (20 individuals – 37.1 %) prognosis. Interleukin-12 in serum was investigated in all patients in preoperative period. It was proved that patients who had such cardiovascular events as stroke, transient ischemic attack, myocardial infarction, death, and courses deterioration of multifocal atherosclerosis in any arterial region, increase or clinical presentations onset of ischemia in any organ during the first year after surgical procedure had significantly higher level of interleukin-12 in serum.
About the Authors
A. V. FrolovRussian Federation
SB RAMS
Scientific-Research Institute for Complex Studying of Cardiovascular Diseases
650022
Sosnovyi bulvar, 6
650029
Voroshylov str., 22a
Kemerovo
O. L. Barbarash
Russian Federation
SB RAMS
Scientific-Research Institute for Complex Studying of Cardiovascular Diseases
650022
Sosnovyi bulvar, 6
650029
Voroshylov str., 22a
Kemerovo
References
1. Гавриленко А. В. Прогнозирование результатов реконструкций и вероятности прогрессирования атеросклероза на основании уровня плазменных цитокинов / А. В. Гавриленко, Д. А. Воронов, С. В. Кочетов // Ангиология и сосудистая хирургия. – 2010. – Т. 16, № 3. – С. 146–151.
2. Palmerini T., Marzocchi A., Marrozzini C. et al. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis // Eur. J. Cardiothorac. Surg. 2007. Vol. 31. P. 685–690.
3. Stoner L., Lucero A. A., Palmer B. R. et al. Inflammatory biomarkers for predicting cardiovascular disease // Clin. Biochem. 2013. Vol. 46. P. 1353–1371.
4. Залесский В. Н. Аутоиммунные и иммуновоспалительные процессы при атеросклерозе, его нутриентопрофилактика и терапия / В. Н. Залесский, Т. И. Гавриленко. – Киев: Вiпол, 2008. – 592 с.
5. Витковский Ю. А. Система гемостаза, лейкоцитарно-тромбоцитарные взаимоотношения, белки острой фазы воспаления и цитокины у больных с различными формами ишемической болезни сердца / Ю. А. Витковский [и др.] // Тромбоз, гемостаз и реология. – 2009. – № 1. – С. 49–63.
6. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways // Physiol. Rev. 2006. Vol. 86. P. 515–581.
7. Bui Q. T., Prempeh M., Wilensky R. L. Atherosclerotic plaque development // Int. J. Biochem. Cell Biol. 2009. Vol. 41, N 11. P. 2109–2123.
8. Packard R. R. S., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction // Clin. Chem. 2008. Vol. 54. P. 24–38.
9. Козлов В. А. Вакцины против атеросклероза: состояние проблемы и перспективы ее развития / В. А. Козлов, М. И. Душкин, Е. И. Верещагин // Цитокины и воспаление. – 2008. – Т. 7, № 1. – С. 8–14.
10. Zhou R. H., Shi Q., Gao H. Q. et al. Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population // J. Atheroscler. Thromb. 2001. Vol. 8. P. 30–32.
11. Yong K., Dogra G., Boudville N. et al. Interleukin-12 is associated with arterial stiffness in healthy individuals // Am. J. Hypertens. 2013. Vol. 26. P. 159–162.
Review
For citations:
Frolov A.V., Barbarash O.L. Clinical and prognostic importance of assessment of interleukin-12 blood concentration in patients with multifocal atherosclerosis after carotid endarterectomy. Ateroscleroz. 2014;10(2):31-36. (In Russ.)